Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.

Advanced COPD tied to reduced BMI, hand grip strength, respiratory function

05 Oct 2020

Advanced stages of chronic obstructive pulmonary disease (COPD) are associated with significantly lower body mass index (BMI), fat-free body mass, hand grip strength, and respiratory and skeletal muscle functions, reports a recent study.

COPD patients aged ≥40 years who were followed for at least 1 year were included in this prospective observational study, which sought to assess nutritional statuses of COPD patients in four categories of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2015 classification, as well as evaluate associations of BMI and fat-free mass index with respiratory and skeletal muscle strengths.

The authors recorded the patients’ medical histories, smoking status, and anthropometric, spirometry, and hand grip strength measurements.

A total of 463 COPD patients were included and classified according to GOLD as follows: group A (n=119), group B (n=58), group C (n=117), and group D (n=169). Patients in group D were older than those in other groups (p=0.001). No between-group difference was found in terms of sex (p=0.163).

Group D had significantly reduced fat-free body mass compared with group A (p=0.014). BMI was also lower in groups C and D than in other groups (p=0.001). In addition, a significant decreasing trend in spirometry and hand grip strength was observed toward group D (p<0.001 for both).

“Nutritional status should be routinely monitored and considered an important indicator in COPD,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Stephen Padilla, 2 days ago
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.